Clinical Trials Browser

Phase 2 × Smoldering Multiple Myeloma × Bortezomib × Clear all

NCT00983346 2016-07-11

Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients

Phase 2 Terminated

17 enrolled 5 charts

Smoldering Multiple Myeloma, Multiple Myeloma, Neoplasms, Neoplasms, Plasma Cell